
    
      This double blinded RCT will help to ascertain the usefulness of prophylactic antibiotics in
      the management of uncomplicated dog bites, utilizing currently best available antibiotics
      (Augmentin) and an important clinical outcome of infection.

      By enrolling 100-150 patients in this pilot trial as part of a k-award the investigators plan
      to utilize the point estimates of infection, side effects and other important outcomes and
      incorporate these into a cost most to determine the most cost effective management of these
      wounds and to determine if further study is warranted based on the findings.
    
  